(In March 16 story, removes "ratings agency" in final paragraph and corrects to "data and analytics company") By Maggie Fick ...
Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick ...
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a ...
Telmisartan, an FDA-approved blood pressure drug, could boost a certain cancer treatment's effectiveness against tumors, a ...
The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.
Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can ...
Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about ...
Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
The FDA has given the all-clear to Corcept’s class-first Lifyorli (relacorilant) to treat adults with platinum-resistant ...
Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used ...
Swiss drugmaker Novartis on Friday agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results